Dr. Alex Belser joins us to further discuss EMBARK and how his passion for training psychedelic therapists led to the development of a broadly applicable model that includes all aspects of psychedelic experiences. With the recent rejection of MDMA-assisted therapy by the FDA, we discuss the future role of psychotherapy, in contrast to more minimal psychological support, in future psychedelic medicine. We also discuss how you might get involved in psychedelic-assisted therapy (spoiler alert: there are no clear paths).

Humans are natural storytellers, for better or worse. How can we become more aware of the stories that embed our lives? How do psychedelics help us see the stories that we live inside and help us have more agency about being an author to our stories? Our guest Jennifer Beman is a documentary film editor who has created a method for visual story-telling called BioGraffs. Hear her describe how BioGraffs can be used to get underneath language and serve as a tool for a range of applications including therapy, talking about sex, resolving conflict within couples, and psychedelic integration.

Dr. William Brennan describes EMBARK, a transdiagnostic flexible model of psychedelic facilitation that builds on existing approaches in clinical research of psychedelic-assisted therapy. He describes the six clinical domains and four care cornerstones, and how they can be flexibly applied to a range of conditions and settings. We discuss some of the pros and cons of a unifying model of change in psychedelics, as well as the tension between individualism in psychotherapy with a systemic, contextual understanding of mental health problems.